Who is the CEO of Novartis?

Vasant (Vas) Narasimhan, since 2018, as the AsOf record states with its sources.

Record

Novartis as of November 8, 2026 · AsOf

organization

Novartis

Novartis is a Swiss-American multinational pharmaceutical corporation, headquartered in Basel. Its CEO is Vasant (Vas) Narasimhan, since 2018.

CEO: Vasant (Vas) Narasimhan since 2018 sec.gov
Headquarters: Basel sec.gov
Ticker: NVS · NYSE sec.gov

Read the record as of a date

Compare the record on two dates →

State as of 2026-11-08

2 assertedThe record stands behind this value for the day asked: two independent sources agree, or a primary source states it (alone, at confidence 0.7 or more). Everything else stays on the record, labelled.More in About → facts

Novartis: state as of 2026-11-08, one row per fact with its value, date, confidence and sources
fact	value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →

Latest

0 dated events · full timeline →

No dated events on the record yet.

Releases, deals, appointments and policy changes land here once a checked source dates them.

Every claim on the timeline, including undated ones →

Financials

latest period on record · change vs prior year

Net income

$13.97B

2025-12-31+17.0%

every net income figure →

Operating income

$17.64B

2025-12-31+21.3%

every operating income figure →

Total assets

$110.95B

2025-12-31+8.5%

As reported in the linked filings, which may be restated. Not investment advice.

State changes since 2026-05-12

0 changes

No changes since 2026-05-12.

Widen the window with the since date, or compare two dates with the diff.

The full timeline →

About this record

Identifiers9 keys · schema.org snippet

AsOf ID: ent_novartis
Wikidata: Q507154
X: Novartis
website: www.novartis.com
SEC CIK: 0001114448
fiscal year end: 12-31
SIC industry: Pharmaceutical Preparations (2834)
incorporated in: V8
ticker: NVS

Cite this record in schema.org

"sameAs": ["https://www.wikidata.org/wiki/Q507154", "https://asof.is/record/novartis"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_novartis" }

Paste into the entity's JSON-LD. Why and how.

Sources on this entity3 sites · 63 citations

sec.govprimary · 59

61 claims on record, 18 currently valid, 43 superseded. Last change 2025-12-31.

shares outstanding	2025-12-31sec.gov: 1 source for shares outstanding, claim clm_29E1C56666EB	2025-12-31	0.95	sec.gov: 1 source for shares outstanding, claim clm_29E1C56666EB
total equity	2025-12-31sec.gov: 1 source for total equity, claim clm_6DC4BBC10979	2025-12-31	0.95	sec.gov: 1 source for total equity, claim clm_6DC4BBC10979